Article Name Clinical & Diagnostic

Modified Wellness Launches EXOMIND™ for Drug-Free Depression Treatment

Utilizing advanced TMS technology, EXOMIND™ offers a drug-free, precision-based solution for mood regulation and cognitive enhancement in clinical and wellness settings.

14th April, 2025


Hamamatsu Photonics Partners with Sirona Dx to Expand Access to Spatial Proteomics Technology

New collaboration removes adoption barriers by offering streamlined evaluation of MoxiePlex systems through a CLIA-accredited lab, combining imaging expertise with validated spatial biology support.

14th April, 2025


Cytonics Concludes Phase 1 Clinical Trial for CYT-108 in Osteoarthritis Treatment – U.S.

Milestone Marks Completion of First-in-Human Study for Innovative OA Therapy

02nd April, 2025


NUS Researchers Develop Microneedle Tech for Faster Diabetic Wound Healing

Innovative Solution Aims to Improve Recovery and Reduce Complications in Diabetes Care

27th March, 2025


Newronika’s AlphaDBS Secures CE Mark for Adaptive Deep Brain Stimulation System

Next-generation closed-loop DBS device now approved in Europe, offering real-time, personalized neuromodulation for Parkinson’s and other neurological disorders.

25th March, 2025


Immunovia’s Next-Gen Blood Test Outperforms CA19-9 in Detecting Early-Stage Pancreatic Cancer

New results from the VERIFI study show Immunovia's test accurately detects 77% of early-stage cases and maintains strong specificity across diverse high-risk groups—strengthening commercial launch plans for Q3 2025.

25th March, 2025


VolitionRx Unveils Promising Data: Nu.Q® Immunoassay Detects 21 Cancers, Eyes Multi-Licensing Deals

With low false positives and broad detection capabilities, Volition’s Nu.Q® test could reshape the $20B liquid biopsy market, as the company advances licensing talks with major diagnostic players.

24th March, 2025


Clario Expands Neuroscience Capabilities with Acquisition of NeuroRx

Strategic move strengthens Clario’s leadership in medical imaging and bolsters expertise in multiple sclerosis and neurological drug development.

17th March, 2025


Fuse Oncology and ACRO Partner to Enhance Radiation Oncology with ACROPath Integration

Strategic Agreement Brings Evidence-Based Clinical Pathways to Radiation Oncology Workflows, Improving Care Quality and Efficiency

14th March, 2025


Baird Medical Gains Indonesian Regulatory Approval for Microwave Ablation Technology

Approval paves the way for broader adoption of Baird Medical’s minimally invasive treatment for tumor ablation, expanding access to advanced cancer care in Indonesia.

11th March, 2025


Beckman Coulter Secures FDA Clearance for DxC 500i Clinical Analyzer

The integrated clinical chemistry and immunoassay system enhances efficiency, streamlines lab workflows, and delivers accurate diagnostics in a compact design.

11th March, 2025


Lunit AI Boosts Cancer Detection in Largest Single-Reading Mammography Study

World’s first large-scale prospective study confirms AI-assisted single-reading mammography improves cancer detection, optimizes workflow efficiency, and reduces radiologist workload.

11th March, 2025


CLEW Launches AI-Powered Sepsis Virtual Unit to Strengthen SEP-1 Compliance

The new solution leverages real-time data and AI-driven insights to enhance early sepsis detection, optimize clinical workflows, and improve patient outcomes.

11th March, 2025


Zimmer Biomet Wins FDA Nod for Metal-Safe Knee Implant

Zimmer Biomet Secures FDA Clearance for Persona® Revision SoluTion™ Femur, Expanding Options for Metal-Sensitive Knee Implant Patients

10th March, 2025


Synergy Laboratories Introduces AI-Powered Genius™ Digital Diagnostics System for Advanced Cervical Cancer Screening

First in the Gulf Coast to launch Hologic’s FDA-cleared digital cytology system, enhancing diagnostic accuracy and expanding access to expert pathology insights.

05th March, 2025


Optellum and Volpara Health Partner to Enhance AI-Driven Cancer Risk Assessment

Strategic agreement integrates Optellum’s AI-powered lung nodule analysis with Volpara’s early cancer detection tools, enabling a more comprehensive approach to patient risk evaluation.

05th March, 2025


Sysmex America Expands Automated Hematology Line with XQ-320™ for Fast, Reliable CBC Testing

Designed for physician office labs and stat labs, the compact XQ-320™ delivers rapid results in under 60 seconds with enhanced diagnostic capabilities, minimal maintenance, and the industry-first BeyondCare℠ Quality Monitor.

04th March, 2025


Seonix Bio Launches SightScore™, the First Clinical PRS Test for Glaucoma in the U.S.

Early glaucoma detection, SightScore™ empowers eye care professionals with advanced genetic insights to identify high-risk individuals before symptoms appear, paving the way for proactive vision care.

03rd March, 2025


Medtech Special

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer